Skip to content

Insider · CIK 0001579887

Backenroth Samuel

Reports to the SEC for 2 companies · NEW YORK, NY

Transactions

32

Companies

2

Filings

8

CIK

0001579887

Forms 4 and 5

Insider transactions

32 trades
DateCompanyValue
2023-03-31Notable Labs, Ltd.M Exercise/Conversion—
2023-03-31Notable Labs, Ltd.Restricted Stock UnitsM Exercise/Conversion—
2020-12-29NeuBase Therapeutics, Inc.Stock option (right to buy)A Award—
2020-04-30NeuBase Therapeutics, Inc.P Purchase+$6,000
2019-07-12NeuBase Therapeutics, Inc.Employee stock option (right to buy)J Other—
2019-07-12NeuBase Therapeutics, Inc.Employee stock option (right to buy)A Award—
2017-10-16NeuBase Therapeutics, Inc.Stock Option (right to buy)A Award—
2017-04-10NeuBase Therapeutics, Inc.P Purchase+$50K
2017-04-10NeuBase Therapeutics, Inc.Warrants (right to buy)P Purchase—
2016-06-20NeuBase Therapeutics, Inc.P Purchase+$1,291.5
2016-06-20NeuBase Therapeutics, Inc.P Purchase+$28.9
2016-06-20NeuBase Therapeutics, Inc.P Purchase+$542
2016-06-20NeuBase Therapeutics, Inc.P Purchase+$23.04
2016-06-20NeuBase Therapeutics, Inc.P Purchase+$5,112
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$484.88
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$526.49
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$35.42
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$590.64
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$172.8
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$610.56
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$2,643.78
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$1,197.64
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$579.6
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$135.02
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$303.61
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$34.375
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$508.56
2016-05-23NeuBase Therapeutics, Inc.P Purchase+$102.63
2016-01-07NeuBase Therapeutics, Inc.A Award—
2015-03-10NeuBase Therapeutics, Inc.OptionA Award—
2015-02-06NeuBase Therapeutics, Inc.P Purchase+$10.1K
2014-02-03NeuBase Therapeutics, Inc.OptionA Award—

Recent filings

8